Drawing for AET

USPTO serial 87216390

AET

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
AGOSTO, GISELLE MARIE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Henry Roske

Henry Roske H.Roske & Associates LLP350 5th Avenue, STE 5220New York, NY 10118

Goods and services

ClassDescriptionStatusFirst use
005generic medicines, in the form of capsules and tablets, for the purposes of pain relief, allergy relief, regulation of blood pressure, and metabolic regulation.; diagnostic preparations for medical purposesACTIVE—
035providing of commercial and technical information relating to business strategies; providing of commercial information relating to generic medicines and medical devices, namely, providing information for the optimization supply chain management of generic medicines and medical devices; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; providing business information for the optimization of distribution networks in the nature of supply chain and distribution processes relating to generic medicines and medical devicesACTIVE—
040Consultancy in the field of manufacture of medicines, pharmaceuticals and medical devicesACTIVE—
042scientific and technological services in the field of research, development and analysis of pharmaceutical products and medical devices; pharmaceutical drug development services; consulting services in the fields of laboratory testing, pharmaceutical research and developmentACTIVE—
044medical advisory services in the field of testing, diagnostics and monitoring of pharmaceutical products and medical devices; medical consultancy in the field of immunologyACTIVE—
045advisory services in the area of regulatory compliance consulting relating to medicines and medical devicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 7, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 7, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 5, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 5, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 10, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 10, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 21, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 5, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 5, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Mar 5, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 5, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 5, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 13, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 13, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 13, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 15, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 14, 2017ALIEASSIGNED TO LIE—
Jul 20, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 7, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 7, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 7, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 3, 2017DOCKASSIGNED TO EXAMINER—
Nov 1, 2016MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 31, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 29, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance